FDA Approves New Lung Cancer Drug with Fewer Side Effects

A newly approved lung cancer treatment offers hope for patients with a rare form of the disease, showing promising results with significantly fewer harsh side effects than existing options.

The drug targets a specific genetic mutation affecting about 2% of lung cancer patients.